Article Contents ::
- 1 Details About Generic Salt :: Ceftriax
- 2 Main Medicine Class:: Antibiotic,cephalosporin
- 3 (SEFF-TRY-AXE-own SO-dee-uhm) Rocephin Class: Antibiotic/cephalosporin
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Ceftriax
Main Medicine Class:: Antibiotic,cephalosporin
(SEFF-TRY-AXE-own SO-dee-uhm)
Rocephin
Class: Antibiotic/cephalosporin
Drugs Class ::
Action Inhibits mucopeptide synthesis in bacterial cell wall.
Indications for Drugs ::
Indications Treatment of infections of lower respiratory tract, skin and skin structures, bone and joint, urinary tract; treatment of pelvic inflammatory disease, intra-abdominal infections, gonorrhea, meningitis and septicemia due to susceptible microorganisms; preoperative prophylaxis. Unlabeled use(s): Treatment of Lyme disease in patients refractory to penicillin G.
Drug Dose ::
Route/Dosage
Infection
ADULTS: IV/IM 1–2 g/day or in equally divided doses q 12 hr (maximum 4 g/day). CHILDREN: IV/IM 50–75 mg/kg/day in equally divided doses q 12 hr (maximum 2 g/day).
Uncomplicated Gonococcal Infections
ADULTS: IM 250 mg as single dose.
Surgical Prophylaxis
ADULTS: IV/IM 1 g as single dose ½-2 hr before surgery.
Pediatric Meningitis
CHILDREN: IV/IM 75 mg/kg as loading dose then 100 mg/kg/day in divided doses q 12 hr (maximum 4 g/day).
Contraindication ::
Contraindications Hypersensitivity to cephalosporins.
Drug Precautions ::
Precautions
Pregnancy: Category B. Lactation: Excreted in breast milk. Children: Cephalosporins may accumulate in neonates. Hypersensitivity: Reactions range from mild to life-threatening. Administer drug with caution to penicillin-sensitive patients due to possible cross-reactivity. Pseudomembranous colitis: Should be considered in patients in whom diarrhea develops. Superinfection: May result in bacterial or fungal over-growth of nonsusceptible micro-organisms.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
GI: Nausea; vomiting; diarrhea; colitis, including pseudomembranous colitis. GU: Renal dysfunction; pyuria; dysuria; reversible interstitial nephritis; hematuria; toxic nephropathy, urinary casts. HEMA: Eosinophilia; neutropenia; lymphocytosis; leukocytosis; thrombocytopenia; decreased platelet function; anemia; aplastic anemia; hemorrhage. HEPA: Hepatic dysfunction; jaundice; abnormal liver function test results. OTHER: Hypersensitivity, including Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis; candidal overgrowth; serum sickness–like reactions (eg, skin rashes, polyarthritis; arthralgia, fever); phlebitis, thrombophlebitis and pain at injection site.
Drug Mode of Action ::
Action Inhibits mucopeptide synthesis in bacterial cell wall.
Drug Interactions ::
Interactions
Aminoglycosides: Increased risk of nephrotoxicity. INCOMPATIBILITIES: Other antimicrobial drugs.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies. Note allergy to cephalosporins or penicillins.
- Obtain specimens for culture and sensitivity before beginning therapy and periodically during treatment.
- Monitor renal function carefully during treatment.
- Monitor for signs of infection, especially fever, and for positive response to antibiotic therapy.
- Assess for signs and symptoms of anaphylaxis (shortness of breath, wheezing, laryngeal spasm). Have resuscitation equipment available.
- Assess for signs of superinfection, such as vaginitis or stomatitis.
- Assess for diarrhea with blood or pus, which may be symptom of pseudomembranous colitis. Symptoms may occur after antibiotic treatment.
- Monitor for coagulation abnormalities. Elevated prothrombin time or abnormal platelet count may occur. If bleeding occurs and PT is prolonged, vitamin K may be indicated.
- Monitor IV site for infiltration, infection, thrombophlebitis and bleeding.
|
Drug Storage/Management ::
Administration/Storage
- Reconstituted solution should be light yellow to amber. Do not administer if solution is cloudy or precipitate is present.
- When giving by IM route, inject deeply into large muscle (eg, upper outer quadrant of gluteus muscle or lateral thigh); massage well.
- When giving by IV route, administer slowly over 3–5 min. Change IV sites q 48–72 hr.
- Reconstituted drug should not be mixed with other antibiotics.
- For piggyback infusion, reconstituted solution may be diluted with D5W or 0.9% Sodium Chloride infused over 30–60 min.
- For preoperative surgical prophylaxis, administer ceftriaxone 50–120 min before surgical incision.
- When reconstituted with 250 ml of diluent, use within 24 hr when stored at room temperature and within 3 days if refrigerated.
- When reconstituted with 100 ml of Sterile Water for Injection, 0.9% Sodium Chloride or 5% Dextrose, use within 3 days when stored at room temperature and within 10 days if refrigerated.
- Completely thaw frozen preparations at room temperature before use; do not refreeze.
- Store sterile powder at room temperature and protect from heat or light.
Drug Notes ::
Patient/Family Education
- Remind patient to check body temperature daily. If fever persists for more than a few days or if high fever (> 102°F) or shaking chills are noted, physician should be notified immediately.
- Advise patient to maintain normal fluid intake while using this medication.
- Instruct diabetic patient to use enzyme-based tests (eg, Clinistix, Testape) for monitoring urine glucose because drug may give false results with other tests.
- Instruct patient to report these symptoms to physician: nausea, vomiting, diarrhea, skin rash, hives, sore throat, bruising, bleeding, muscle or joint pain.
- Advise patient to report signs of superinfection: black “furry” tongue, white patches in mouth, foul-smelling stools, vaginal itching or discharge.
- Warn patient that diarrhea that contains blood or pus may be a sign of serious disorders. Tell patient to seek medical care and not to treat at home.
- Instruct patient to seek emergency care immediately if wheezing or difficulty in breathing occurs.